首页> 外文期刊>Canadian Medical Association Journal: Journal de l'Association Medicale Canadienne >Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study
【24h】

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study

机译:肾脏学咨询和死亡率第四阶段慢性肾脏疾病:a以人群为基础的研究

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Guidelines recommend nephrology referral for people with advanced non-dialysis-dependent chronic kidney disease, based mostly on survival benefits seen in retrospective studies of dialysis patients, which may not be generalizable to the broader population with chronic kidney disease. We aimed to examine the association between outpatient nephrology consultation and survival in adults with stage 4 chronic kidney disease. METHODS: We linked population-based laboratory and administrative data from 2002 to 2014 in Alberta, Canada, on adults with stage 4 chronic kidney disease (sustained estimated glomerular filtration rate >= 15 to 90 d), who had never had kidney failure and had had no outpatient nephrology encounter in the 2 years preceding study entry. Participants who had never had an outpatient nephrology visit before renal replacement treatment were considered "unexposed." Participants who saw a nephrologist during follow-up were considered "unexposed" before the first outpatient nephrology visit and "exposed" thereafter. The primary outcome was all-cause mortality. RESULTS: Of the 14 382 study participants (median follow-up 2.7 yr), 64% were aged >= 80 years, 35% saw a nephrologist and 66% died during follow-up. Nephrology consultation was associated with lower mortality (hazard ratio [HR] 0.88, 95% confidence interval [CI] 0.82-0.93). The association was strongest in people = 90 years (HR 1.05, 95% CI 0.88-1.25). INTERPRETATION: The survival benefit of nephrology consultation in adults with stage 4 chronic kidney disease may be smaller than expected and appears to attenuate with increasing age. These findings should inform recommendations for nephrology referral considering the advanced age of the patient population meeting current referral criteria.
机译:背景:指南推荐肾脏学推荐为先进non-dialysis-dependent慢性肾脏疾病,主要是基于生存的好处透析病人的回顾性研究可能并不适用于更广泛的吗人口与慢性肾脏疾病。检查门诊之间的联系成人肾脏学咨询和生存第四阶段慢性肾脏疾病。以人群为基础的实验室和从2002年到2014年在阿尔伯塔省管理数据,加拿大,在成人阶段4慢性肾脏(持续的肾小球疾病滤过率> = 15 - 90 d),从来没有肾衰竭和没有门诊肾脏病学会遇到前2年学习条目。门诊病人的肾脏肾前访问替代治疗被认为是“未曝光。”在随访中被认为是“未曝光”之前第一次门诊肾脏学和访问“暴露”。全因死亡率。参与者(平均随访2.7年),64%的人> = 80岁,35%的人看见一个肾脏和66%随访中死亡。是降低死亡率(危险比[HR] 0.88, 95%可信区间[CI]0.82 - -0.93)。人= 90年(HR 1.05, 95% CI 0.88 - -1.25)。解释:生存的好处肾脏学咨询在成人阶段4慢性肾脏疾病可能小于预期,似乎减弱而增加的年龄。对肾脏病学会推荐考虑先进的当前病人的年龄人口会议推荐标准。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号